FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154079330> ?p ?o ?g. }

• W2154079330 endingPage "686" @default.
• W2154079330 startingPage "675" @default.
• W2154079330 abstract "Background Alcohol withdrawal syndrome (AWS) occurs in 16 to 31% of intensive care unit (ICU) patients after cessation of sedation. There exist many preventive and therapeutic strategies, but no systematic review (SR) has been published on this topic so far. We aimed to perform a synopsis of all controlled trials of AWS prevention and therapy in ICU published between 1971 and 30 March 2011 following the “Preferred Reporting Items for Systematic Reviews and Meta-Analyses” (PRISMA) statement. Methods We performed a MEDLINE search with the terms “alcohol” AND “ICU” as well as “alcohol withdrawal” AND “intensive care.” All publications that matched our eligibility criteria were analyzed according to our predefined criteria. Results We identified 6 controlled trials about AWS prevention and 8 about AWS therapy in ICUs. For AWS prevention, benzodiazepines (BZO), ethanol (EtOH), and clonidine were evaluated as single agents, and BZO, clonidine, clomethiazol and haloperidol were studied in drug combinations. All evaluated single agents and combinations were found to be effective for AWS prevention. Clomethiazol was found to be associated with a higher tracheobronchitis rate and thus disadvised for critically ill patients. For AWS therapy, BZO, gamma-hydroxybutyric acid (GHB), and clomethiazol were evaluated in randomized controlled trials as single agents and phenobarbital, clonidine, and haloperidol as adjuncts. All evaluated regimens were found to be effective for AWS therapy. Overall, in the ICU, BZO were found to be superior to GHB and clomethiazol regarding safety and efficacy. Furthermore, 4 cohort trials with historical control groups evaluated the effect of the implementation of a standardized protocol of BZO therapy for AWS in ICUs. All of these 4 studies found better outcome for the intervention groups. Conclusions Based on the evidence of this SR, EtOH or BZO can be advised for AWS prevention on ICU patients with alcohol dependence, but EtOH is not allowed for therapy of AWS. AWS therapy should be standardized and based on symptom-triggered BZO administration. Alpha2-agonists and haloperidol should be added for autonomic and productive psychotic symptoms." @default.
• W2154079330 created "2016-06-24" @default.
• W2154079330 creator A5016186200 @default.
• W2154079330 creator A5029931677 @default.
• W2154079330 creator A5033029729 @default.
• W2154079330 creator A5036068033 @default.
• W2154079330 creator A5057165859 @default.
• W2154079330 date "2012-11-26" @default.
• W2154079330 modified "2023-10-01" @default.
• W2154079330 title "Prevention and Therapy of Alcohol Withdrawal on Intensive Care Units: Systematic Review of Controlled Trials" @default.
• W2154079330 cites W1524213252 @default.
• W2154079330 cites W1592008739 @default.
• W2154079330 cites W165234237 @default.
• W2154079330 cites W177478450 @default.
• W2154079330 cites W1977452921 @default.
• W2154079330 cites W1984764841 @default.
• W2154079330 cites W1988977633 @default.
• W2154079330 cites W1996457574 @default.
• W2154079330 cites W2001660166 @default.
• W2154079330 cites W2007938047 @default.
• W2154079330 cites W2024391775 @default.
• W2154079330 cites W2026891160 @default.
• W2154079330 cites W2031784362 @default.
• W2154079330 cites W2034006252 @default.
• W2154079330 cites W2044366649 @default.
• W2154079330 cites W2058222907 @default.
• W2154079330 cites W2058298351 @default.
• W2154079330 cites W2063648839 @default.
• W2154079330 cites W2064394897 @default.
• W2154079330 cites W2064621719 @default.
• W2154079330 cites W2072556263 @default.
• W2154079330 cites W2078974586 @default.
• W2154079330 cites W2085486935 @default.
• W2154079330 cites W2087654707 @default.
• W2154079330 cites W2098373009 @default.
• W2154079330 cites W2099472290 @default.
• W2154079330 cites W2108670730 @default.
• W2154079330 cites W2121393522 @default.
• W2154079330 cites W2132247452 @default.
• W2154079330 cites W2134093430 @default.
• W2154079330 cites W2138725067 @default.
• W2154079330 cites W2141911929 @default.
• W2154079330 cites W2405749251 @default.
• W2154079330 cites W2410140377 @default.
• W2154079330 cites W2417298530 @default.
• W2154079330 cites W4251666672 @default.
• W2154079330 cites W83643681 @default.
• W2154079330 doi "https://doi.org/10.1111/acer.12002" @default.
• W2154079330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23550610" @default.
• W2154079330 hasPublicationYear "2012" @default.
• W2154079330 type Work @default.
• W2154079330 sameAs 2154079330 @default.
• W2154079330 citedByCount "39" @default.
• W2154079330 countsByYear W21540793302013 @default.
• W2154079330 countsByYear W21540793302014 @default.
• W2154079330 countsByYear W21540793302015 @default.
• W2154079330 countsByYear W21540793302016 @default.
• W2154079330 countsByYear W21540793302017 @default.
• W2154079330 countsByYear W21540793302018 @default.
• W2154079330 countsByYear W21540793302019 @default.
• W2154079330 countsByYear W21540793302020 @default.
• W2154079330 countsByYear W21540793302021 @default.
• W2154079330 countsByYear W21540793302022 @default.
• W2154079330 countsByYear W21540793302023 @default.
• W2154079330 crossrefType "journal-article" @default.
• W2154079330 hasAuthorship W2154079330A5016186200 @default.
• W2154079330 hasAuthorship W2154079330A5029931677 @default.
• W2154079330 hasAuthorship W2154079330A5033029729 @default.
• W2154079330 hasAuthorship W2154079330A5036068033 @default.
• W2154079330 hasAuthorship W2154079330A5057165859 @default.
• W2154079330 hasConcept C126322002 @default.
• W2154079330 hasConcept C168563851 @default.
• W2154079330 hasConcept C17744445 @default.
• W2154079330 hasConcept C177713679 @default.
• W2154079330 hasConcept C185592680 @default.
• W2154079330 hasConcept C189708586 @default.
• W2154079330 hasConcept C199539241 @default.
• W2154079330 hasConcept C2776153860 @default.
• W2154079330 hasConcept C2776376669 @default.
• W2154079330 hasConcept C2776814716 @default.
• W2154079330 hasConcept C2778399450 @default.
• W2154079330 hasConcept C2779473830 @default.
• W2154079330 hasConcept C2780873584 @default.
• W2154079330 hasConcept C2781066024 @default.
• W2154079330 hasConcept C2987404301 @default.
• W2154079330 hasConcept C42219234 @default.
• W2154079330 hasConcept C535046627 @default.
• W2154079330 hasConcept C55493867 @default.
• W2154079330 hasConcept C71924100 @default.
• W2154079330 hasConceptScore W2154079330C126322002 @default.
• W2154079330 hasConceptScore W2154079330C168563851 @default.
• W2154079330 hasConceptScore W2154079330C17744445 @default.
• W2154079330 hasConceptScore W2154079330C177713679 @default.
• W2154079330 hasConceptScore W2154079330C185592680 @default.
• W2154079330 hasConceptScore W2154079330C189708586 @default.
• W2154079330 hasConceptScore W2154079330C199539241 @default.
• W2154079330 hasConceptScore W2154079330C2776153860 @default.
• W2154079330 hasConceptScore W2154079330C2776376669 @default.

• next